HEXO Corp. (TSX:HEXO) Stock Price & Quote Analysis

HEXO Stock Overview

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada.

HEXO fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	1/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Revenue is forecast to grow 12.36% per year

Risk Analysis

Shareholders have been substantially diluted in the past year

Currently unprofitable and not forecast to become profitable over the next 3 years

Has less than 1 year of cash runway

Does not have a meaningful market cap (CA$91M)

My Notes

New

Notes are coming soon

HEXO Corp. Competitors

Acreage Holdings

CNSX:ACRG.A.U

US$105.3m

BioSyent

TSXV:RX

CA$88.0m

Green Organic Dutchman Holdings

CNSX:TGOD

CA$62.2m

iAnthus Capital Holdings

CNSX:IAN

CA$160.3m

Price History & Performance

Summary of all time highs, changes and price drops for HEXO
Historical stock prices
Current Share Price	CA$2.11
52 Week High	CA$13.16
52 Week Low	CA$1.23
Beta	1.94
1 Month Change	51.80%
3 Month Change	-43.13%
1 Year Change	-76.81%
3 Year Change	-97.73%
5 Year Change	-98.89%
Change since IPO	-97.57%

Recent updates

HEXO Corp. (TSE:HEXO) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Dec 16

Shareholder Returns

	HEXO	CA Pharmaceuticals	CA Market
7D	5.0%	-3.7%	0.6%
1Y	-76.8%	-59.1%	-0.6%

Return vs Industry: HEXO underperformed the Canadian Pharmaceuticals industry which returned -59.1% over the past year.

Return vs Market: HEXO underperformed the Canadian Market which returned -0.6% over the past year.

Price Volatility

Is HEXO's price volatile compared to industry and market?
HEXO volatility
HEXO Average Weekly Movement	14.1%
Pharmaceuticals Industry Average Movement	14.2%
Market Average Movement	9.9%
10% most volatile stocks in CA Market	19.1%
10% least volatile stocks in CA Market	3.9%

Stable Share Price: HEXO is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 14% a week.

Volatility Over Time: HEXO's weekly volatility (14%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2013	n/a	Charlie Bowman	https://www.hexocorp.com

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names.

HEXO Corp. Fundamentals Summary

How do HEXO's earnings and revenue compare to its market cap?
HEXO fundamental statistics
Market Cap	CA$90.58m
Earnings (TTM)	-CA$1.01b
Revenue (TTM)	CA$176.69m

0.5x

P/S Ratio

-0.1x

P/E Ratio

Is HEXO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
HEXO income statement (TTM)
Revenue	CA$176.69m
Cost of Revenue	CA$237.74m
Gross Profit	-CA$61.05m
Other Expenses	CA$951.54m
Earnings	-CA$1.01b

Last Reported Earnings

Oct 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-23.59
Gross Margin	-34.55%
Net Profit Margin	-573.10%
Debt/Equity Ratio	99.4%

How did HEXO perform over the long term?

See historical performance and comparison

HEXO Stock Overview

Rewards

Risk Analysis

HEXO Corp. Competitors

CNSX:ACRG.A.U

US$105.3m

TSXV:RX

CA$88.0m

CNSX:TGOD

CA$62.2m

CNSX:IAN

CA$160.3m

Price History & Performance

Recent News & Updates

HEXO Corp Wins Complete Dismissal of Putative Québec Shareholder Class Action

HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash Brands

Consensus revenue estimates fall by 17%

Price target decreased to CA$0.20

First quarter 2023 earnings: EPS and revenues miss analyst expectations

HEXO Corp., Annual General Meeting, Jan 31, 2023

Recent updates

HEXO Corp Wins Complete Dismissal of Putative Québec Shareholder Class Action

HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash Brands

Consensus revenue estimates fall by 17%

Price target decreased to CA$0.20

First quarter 2023 earnings: EPS and revenues miss analyst expectations

HEXO Corp., Annual General Meeting, Jan 31, 2023

Consensus EPS estimates fall by 12%

High number of new and inexperienced directors

Consensus EPS estimates fall by 12%

Consensus EPS estimates fall by 12%

Consensus forecasts updated

Full year 2022 earnings: EPS and revenues miss analyst expectations

Sundial Growers Inc. (NasdaqCM:SNDL) acquired Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

No longer forecast to breakeven

HEXO Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Price target decreased to CA$0.29

High number of new and inexperienced directors

HEXO Corp. has completed a Follow-on Equity Offering in the amount of $40 million.

Sundial Growers Inc. (NasdaqCM:SNDL) entered into a purchase agreement to acquire Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

HEXO Corp. Announces CFO Changes, Effective May 16, 2022

HEXO Corp. Announces to Close Its Belleville Facility and Transition Its Operations

Forecast to breakeven in 2024

High number of new and inexperienced directors

Consensus EPS estimates fall by 718%

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

High number of new and inexperienced directors

HEXO Corp. Announces Refreshed Board of Directors

HEXO Provides Nasdaq Listing Update

Olegna Holdings Inc acquired a 25% stake in Belleville Complex Inc from HEXO Corp. (TSX:HEXO) for $10.1 million.

High number of new directors

Consensus revenue estimates fall by 12%

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

HEXO Corp. Reports Impairment Charges for the First Quarter Ended October 31, 2021

The Consensus EPS Estimates For HEXO Corp. (TSE:HEXO) Just Fell Dramatically

Price target decreased to CA$2.61

High number of new directors

Director & Co-Founder Sebastien St-Louis has left the company

Independent Chairman of the Board recently bought CA$260k worth of stock

Full year 2021 earnings released: CA$0.90 loss per share (vs CA$7.06 loss in FY 2020)

Full year 2021 earnings released: CA$0.90 loss per share (vs CA$7.06 loss in FY 2020)

Price target decreased to CA$4.95

Price target decreased to CA$6.12

HEXO Corp. (TSX:HEXO) completed the acquisition of 48North Cannabis Corp. (TSXV:NRTH) from Canopy Growth Corporation (TSX:WEED), Wallington Investment Holdings Limited and others.

HEXO Corp. (TSX:HEXO) completed the acquisition of 9037136 Canada Inc. (“Redecan”) from Will Montour, Pete Montour and family.

Price target decreased to CA$7.61

Does HEXO (TSE:HEXO) Have A Healthy Balance Sheet?

Third quarter 2021 earnings released: CA$0.17 loss per share (vs CA$0.26 loss in 3Q 2020)

HEXO Corp. Reports Impairment of Property, Plant and Equipment for the Third Quarter Ended April 30, 2021

Price target decreased to CA$8.75

Consensus revenue estimates fall to CA$119.5m

HEXO Corp. Wins Dismissal of Ny State Court Shareholder Class Action

Forecast to breakeven in 2023

HEXO Corp. (TSX:HEXO) completed the acquisition of Zenabis Global Inc. (TSX:ZENA).

HEXO Corp. (TSX:HEXO) entered into a definitive agreement to acquire 9037136 Canada Inc. from Will Montour, Pete Montour and family for approximately CAD 950 million.

HEXO Corp. (TSX:HEXO) agreed to acquire US Production Facility In Colorado.

HEXO Corp Receives Control Union Medical Cannabis Standard GACP Certification

Is HEXO (TSE:HEXO) Using Debt In A Risky Way?

Consensus forecasts updated

Second quarter 2021 earnings released: CA$0.17 loss per share (vs CA$4.53 loss in 2Q 2020)